Navigation Links
Czura Thornton Announces Intention to Acquire Global Central Laboratory Business of MDS Pharma Services

LONDON, Oct. 9 /PRNewswire/ -- Private investment firm Czura Thornton today announced it has signed an agreement to acquire the global central laboratory ('GCL') operations of MDS Pharma Services, a business unit of MDS Inc (NYSE: MDZ; TSX: MDS).

GCL, to announce a new brand shortly, provides a comprehensive range of late-stage laboratory and electrocardiogram services supporting clinical trials globally. The business' proprietary leading edge Apollo CLPM(TM) (Central Lab Protocol Management) system offers clients real-time access to study data from around the world. GCL employs 600 people at accredited facilities in Beijing, Hamburg, North Brunswick (New Jersey), Paris, Singapore and Toronto.

In a joint statement, Czura Thornton's founders Tony Czura and Nick Thornton said: "We are delighted to be acquiring MDS's global central laboratory platform and the deep expertise of the people there. Combined with our focus on the consistent delivery of high quality service and the flexibility and responsiveness that private ownership allows, we look forward to seeing renewed strength and growth in the business." They added that, "While we see excellent opportunities for collaboration with Chiltern, a leading CRO also owned by Czura Thornton, the two entities will operate independently."

The transaction is expected to close in the fourth quarter of 2009 and is subject to customary approvals and closing conditions. In addition, the sale of the Central Labs operations in France and Germany is subject to review and consultation with the applicable Works Councils in accordance with labor laws in those countries.

"We are pleased that the agreement with Czura Thornton creates opportunities to build the Central Labs business, which includes world-class facilities and highly skilled people focused on delivering superior client service," said Stephen P. DeFalco, President and Chief Executive Officer of MDS Inc.

About Czura Thornton: Czura Thornton is a private investment group that was founded by Tony Czura and Nick Thornton in 2003. The group, which owns leading CRO Chiltern (, has interests in the life sciences, international trade, property and automotive sectors. In particular Messrs Czura and Thornton have extensive international experience in the laboratory and CRO sectors. For further information see

Contact: Zareena Chattoo; +44 1753 216 611 (U.K.)

SOURCE Czura Thornton

SOURCE Czura Thornton
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early-Stage Breast Cancer Patients
2. Kimberly-Clark Announces Definitive Agreement to Acquire I-Flow Corporation
3. NIAID announces vaccine adjuvant discovery contracts
4. STEMCELL Technologies Inc. Announces Direct Distribution to Spain
5. ONRAD Announces New Partnership with La Maestra Community Health Centers of San Diego, CA
6. NCG Medical Announces Its Participation in Preliminary ARRA 2011 Certification Program
7. Institute for Liberty Announces the Launch of Keeping Small Business Healthy
8. PAREXEL Announces Date of First Quarter Fiscal Year 2010 Earnings Release and Conference Call
9. Medical Travel Company Satori World Medical Announces Relationship with Managing General Underwriter GreenWood International Insurance Services (GWI)
10. Cord Blood America Announces Debt Reduction Tally: $8.7 Million in 2009; $3.7 Million in Third Quarter
11. Tranziger Announces Formation of Global Advisory & Development Team
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... ... been recognized once again for its stellar workplace culture with the company’s Cincinnati ... , Medical Solutions’ Cincinnati office was named a finalist in Cincinnati Business ...
(Date:11/25/2015)... ... 2015 , ... Ministers, senior government and UN agencies, representatives ... of Excellence, and public R&D institutions, civil societies and other partners gathered today ... African Network for Drugs and Diagnostics Innovation, ANDI, Stakeholders Meeting. The three- day ...
(Date:11/25/2015)... Angeles, CA (PRWEB) , ... November 25, 2015 , ... ... da Vinci surgical robot is being more and more widely heralded as a breakthrough ... assisted da Vinci method has over traditional laparoscopic surgery is that it can greatly ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug ... a new cutting edge recovery program that has been 50 years in the making. ... individuals with the purpose to free addicts from the symptoms and negative behaviors of ...
(Date:11/25/2015)... ... ... On November 23rd 2015 Cozy Products, a division of Bird-X Incorporated, ... explains what this means for business moving forward. , The Tri Lite heater business ... to sell personal heaters that reduce energy consumption, are economical and keep people warm ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , 26 november 2015 ... kondigt de geplande investering aan van ten ... de laboratoria en het mondiale hoofdkantoor in ... uitbreiding zal resulteren in extra kantoorruimte en ... aan de groeiende behoeften van de farmaceutische ...
(Date:11/26/2015)... UTRECHT , Nederland, November 26, 2015 ... --> Een nieuwe aanpak combineert ... van gevorderde kanker. ... -->      (Photo: ... van het Leids Universitair Medisch Centrum (LUMC) ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ) ... Pacemaker Market Outlook to 2019 - Rise in Cardiac Disorders ... report to their offering. Boston ... Boston scientific and others. --> ... Biotronik, Boston scientific and others. ...
Breaking Medicine Technology: